Opening of ATP-sensitive potassium channels causes migraine attacks: a new target for the treatment of migraine

Keyphrases

• Placebo 100%
• Migraine Attack 100%
• Migraine Treatment 100%
• New Targets 100%
• Cromakalim 100%
• ATP-sensitive Potassium Channel 100%
• Migraine 42%
• Confidence Interval 28%
• Headache 28%
• Area under the Curve 28%
• Headache Intensity 28%
• Middle Cerebral Artery Velocity 28%
• Placebo-controlled 14%
• Randomized Double-blind 14%
• Observation Period 14%
• Migraine Pathophysiology 14%
• New Drug Targets 14%
• KATP Channel 14%
• Change in Mean 14%
• Intensity Score 14%
• KATP Channel Blockers 14%
• KATP Channel Opener 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Migraine 100%
• Adenosine Triphosphate Sensitive Potassium Channel 100%
• Placebo 72%
• Lemakalim 63%
• Headache 36%
• Pathophysiology 9%
• Disease 9%
• Channel Blocker 9%
• Channel Opener 9%

Neuroscience

• Migraine 100%
• Adenosine Triphosphate Sensitive Potassium Channel 100%
• Placebo 72%
• Headache 36%
• Middle Cerebral Artery 18%
• Crossover Study 9%
• Channel Blocker 9%